Richard Pomerantz
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$1.1MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $1.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 16, 2021 | NIH | STTR Phase I Structure Based Design of Pol-theta inhibitors | $386K | RECOMBINATION THERAPEUTICS LLC with UNIVERSITY OF SOUTHERN CALIFORNIA |
| Sep 18, 2020 | NIH | STTR Phase I Nucleotide inhibitors as precision medicine in breast cancer | $400K | RECOMBINATION THERAPEUTICS LLC with TEMPLE UNIV OF THE COMMONWEALTH |
| Mar 10, 2020 | NIH | STTR Phase I Next-generation precision medicine for targeting recombination-deficient cancers | $299K | RECOMBINATION THERAPEUTICS LLC with TEMPLE UNIV OF THE COMMONWEALTH |
Peer ranks
Federal funding#1,677
Awards as PI#822
Patents#273
Companies
- RECOMBINATION THERAPEUTICS LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 23, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.